openPR Logo
Press release

Colorectal Cancer Treatment Market- Global Outlook 2024

01-16-2017 02:40 PM CET | Health & Medicine

Press release from: TMR – Research Reports

Colorectal cancer is cancer that starts in the colon or rectum. The colon and the rectum are parts of the large intestine, which is the lower part of the body’s digestive system. The colon absorbs water and nutrients from the food and stores waste matter (stool). Stool moves from the colon into the rectum before it leaves the body. Colorectal cancer often begins as a growth called a polyp, which may form on the inner wall of the colon or rectum. Some polyps become cancer over time. Finding and removing polyps can prevent colorectal cancer. During digestion, food moves through the stomach and small intestine into the colon. Most colorectal cancers are adenocarcinomas (cancers that begin in cells that make and release mucus and other fluids). Some of the commonly seen symptoms of colorectal cancer are blood in the weight loss, fatigue, stool, and irregular bowel movements. Colorectal cancer is a result of uncontrolled cell growth that occurs in the appendix, colon, and the rectum region.

Download exclusive Sample of this report: https://goo.gl/7hWaHy

According to American Cancer Society, in United States when men and women are considered individually colorectal cancer is the third prominent cause of cancer-related mortality, and the second prominent cause when both sexes are combined. With the use of fecal occult blood tests and colonoscopies, which check for blood in the stool the deaths from colorectal cancer have decreased. Ageing, fatty diet, excessive consumption of red meat or alcohol, male gender, obesity, smoking are the most commonly observed causes for colorectal cancer. Most colorectal cancers originate as a polyp, a growth in the tissue that lines the internal surface of the rectum or colon and it is common in people older than 50 years of age, and most are not cancer.

Increasing adoption of western diet which are high in fat and low in fiber is expected to boost the growth of colorectal cancer market over the forecast period. Based on diagnosis, colorectal cancer are classified as fecal occult blood tests, stool DNA test, sigmoidoscopy, colonoscopy, virtual colonoscopy, double-contrast barium enema, others.

Based on treatment option, colorectal cancer are classified as surgery, radiation therapy, chemotherapy and targeted therapy. Surgery remains the most effective treatment for colorectal cancer. Radiation therapy reduces the chance of cancer spread or recurrence and is effective as additional or adjuvant therapy either before or after surgery. The segment is expected to grow rapidly over the forecast period due to increasing technological advancement and increasing awareness.

View exclusive Global strategic Business report :
http://www.transparencymarketresearch.com/colorectal-cancer-treatment-market.html

Based on colorectal cancer stage, colorectal cancer has been segmented into stage 0, stage I, stage II, stage III, and stage IV (metastatic). According to National Cancer Institute, in 2016, an estimated 134,490 people in the United States will be diagnosed with colorectal cancer and 49,190 people will die from it. In general, stages 0, I, II, and III are often curable with surgery. Patients with stage II and III rectal cancer receives radiation therapy with chemotherapy either before or after surgery. Patients with stage III colorectal cancer, and some with stage II, receive chemotherapy after surgery to increase the chance of eliminating the disease. Stage IV is not often curable, but it effects can be reduced, and the growth of the cancer and the symptoms of the disease can be managed.

On the basis of regional presence, global colorectal cancer market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to lead the global colorectal cancer market for due to aging population. Due to increase in screening of colorectal cancer and changes in some risk factors such as a decline in smoking and consumption of alcohol is decreasing the rate of new colorectal cancer cases and deaths among adults aged 50 years and above.

Some of the major players in global colorectal cancer market are Hoffmann La Roche, Debiopharm Group, Merck KGaA, Vaccinogen BD, AEterna Zentaris, and Keryx Biopharmaceuticals, Inc., etc.

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Colorectal Cancer Treatment Market- Global Outlook 2024 here

News-ID: 413819 • Views: 244

More Releases from TMR – Research Reports

Power Line Communication Market to Present Highly Lucrative Opportunities for Ma …
Power Line Communication (PLC) is an emerging communication technology which enables data exchange over existing power cables. It uses power grids to communicate between two end-points. PLC technology allow users to control or retrieve data in a half-duplex manner. Furthermore, in this communication method, sender modulates the data, and injects in power cables which can be retrieved by de-modulation at the receiving end. PLC technology is widely used for home
Wood Coatings Market - Roof coatings to Register High Demand | 2025
The global wood coatings market is choc-o-bloc with players and this has served to intensify the competition over the years. Product differentiation is a key tool leveraged by players to steal a march over their competitors. Key factors promoting growth in the market are the soaring construction activities across the globe and the increasing spending capacity of people which has stoked sales of furniture. Another factor catalyzing growth in the global
Welding Materials Market - Thriving Growth In Industrial Application Segments By …
The global welding materials market is growing on account of the thriving growth of application segments such as transportation, building and construction, marine, and automobiles. The growing urbanization in developing nations will drive the growth of this market. The increasing infrastructure development in Asia Pacific will also fuel the growth of the welding materials market. The technological advancements in the automobile industry will also aid the growth of this market.
Intumescent Coatings Market Demand for Improved Fire Safety to Fuel Growth By 20 …
The global intumescent coatings market has remained moderately concentrated as nearly 45% of its overall share was held by three enterprises in 2015. These companies were Sherwin-Williams Co., PPG Industries Inc., and Nobel N.V., finds Transparency Market Research (TMR) in a new study. These companies, besides other prominent market players are continuously making efforts to expand their regional footprint by establishing new manufacturing units. While expanding operations across emerging nations has

All 5 Releases


More Releases for III

Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) Therapeutics - Pipelin …
Mucopolysaccharidosis type III (MPS III), also known as Sanfilippo syndrome, is a progressive disorder that primarily affects brain and spinal cord (central nervous system). People with MPS III generally do not display features at birth, but they begin to show signs and symptoms of this disorder during early childhood. Affected children often initially have delayed speech and behaviour problems. Download the sample report @ https://www.pharmaproff.com/request-sample/1146 In later stages of this disorder, people
Antithrombin III Deficiency Testing Market Growth Dynamics over 2021
Antithrombin III is a non-vitamin, K-dependent protease that naturally blocks abnormal blood clot formation in the bloodstream. Deficiency of antithrombin III causes various blood clot disorders in the human body. For instance, congenital antithrombin III deficiency is a common antithrombin deficiency, which usually occurs when individuals receive the abnormal antithrombin III gene from their parents. This abnormal gene causes abnormal blood clots in the human body which block blood flow
Global Antithrombin III Deficiency Testing Market
The Antithrombin III Deficiency Testing Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Antithrombin deficiencies are mainly divided into two types: type I and type II. The type I antithrombin deficiency is characterized by an inadequate amount of normal antithrombin present in
EXCEEMO Industrial SATA III SSD
Extremely impressive performance, the highest reliability and guaranteed fixed BOM - all in one service package for industrial customers EXCEEMO, the memory and storage specialist from Landsberg am Lech, presents the industrial 2.5“ SATA III Solid-State-Drives with ultra-fast read/write transfer speed of up to 555MB/515MB per second and proven long-term reliability. The noiseless, energy-efficient and particularly robust solid state drives are available both in standard grade (0°/+70°C-MLC/SLC) and in industrial
BioFocus extends collaboration with Usher III Initiative
BioFocus announced today that it has expanded a collaboration with the Usher III Initiative, Inc., a non-profit organization focused on developing treatments for Usher syndrome type III, a rare genetic disorder that causes the loss of hearing and vision. BioFocus and the Usher III Initiative began their collaboration in July 2010 with BioFocus performing an integrated drug discovery program encompassing medicinal chemistry, ADME and biological sciences, aiming at a
NewBlueFX Introduces “Video Essentials III” Effects Plugins
NewBlueFX Introduces “Video Essentials III” Effects Plugins The Video Editor’s Wish List of Tools & Techniques in One Package Video, Multimedia and Technology Editors LA JOLLA, CA (November 04, 2009)— NewBlue, Inc. today launched Video Essentials III, the third and latest offering in its best-selling Video Essentials series of video effects and transitions plugins. NewBlue Video Essentials III provides highly-practical video tools designed to solve everyday production issues. The collection includes Rolling Shutter,